Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 2
2014 2
2016 3
2019 5
2020 7
2021 6
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trial.
Feagan BG, Danese S, Loftus EV Jr, Vermeire S, Schreiber S, Ritter T, Fogel R, Mehta R, Nijhawan S, Kempiński R, Filip R, Hospodarskyy I, Seidler U, Seibold F, Beales ILP, Kim HJ, McNally J, Yun C, Zhao S, Liu X, Hsueh CH, Tasset C, Besuyen R, Watanabe M, Sandborn WJ, Rogler G, Hibi T, Peyrin-Biroulet L. Feagan BG, et al. Among authors: kempinski r. Lancet. 2021 Jun 19;397(10292):2372-2384. doi: 10.1016/S0140-6736(21)00666-8. Epub 2021 Jun 3. Lancet. 2021. PMID: 34090625 Clinical Trial.
ABX464 (obefazimod) for moderate-to-severe, active ulcerative colitis: a phase 2b, double-blind, randomised, placebo-controlled induction trial and 48 week, open-label extension.
Vermeire S, Sands BE, Tilg H, Tulassay Z, Kempinski R, Danese S, Bunganič I, Nitcheu J, Santo J, Scherrer D, Biguenet S, Ehrlich HJ, Steens JM, Gineste P, Sandborn WJ. Vermeire S, et al. Among authors: kempinski r. Lancet Gastroenterol Hepatol. 2022 Nov;7(11):1024-1035. doi: 10.1016/S2468-1253(22)00233-3. Epub 2022 Sep 6. Lancet Gastroenterol Hepatol. 2022. PMID: 36075249 Clinical Trial.
Inflammatory bowel disease induced by bimekizumab.
Wietrzykowska-Grishanovich D, Pleskacz M, Kempiński R. Wietrzykowska-Grishanovich D, et al. Among authors: kempinski r. Prz Gastroenterol. 2022;17(2):175-176. doi: 10.5114/pg.2022.116374. Epub 2022 May 19. Prz Gastroenterol. 2022. PMID: 35664026 Free PMC article. No abstract available.
Non-medical costs of colonoscopy.
Petryszyn PW, Kempiński R, Michałowicz J, Poniewierka E. Petryszyn PW, et al. Among authors: kempinski r. Prz Gastroenterol. 2014;9(5):270-4. doi: 10.5114/pg.2014.46161. Epub 2014 Oct 19. Prz Gastroenterol. 2014. PMID: 25396000 Free PMC article. Review.
Disease duration and age influence CARD15 expression in Crohn's disease.
Poniewierka E, Neubauer K, Kempiński R, Sadakierska-Chudy A. Poniewierka E, et al. Among authors: kempinski r. Postepy Hig Med Dosw (Online). 2016 Jan 5;70:10-3. doi: 10.5604/17322693.1192187. Postepy Hig Med Dosw (Online). 2016. PMID: 26864060 Free article. Review.
26 results